[HTML][HTML] Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy

J Dort, Z Orfi, P Fabre, T Molina, TC Conte… - Nature …, 2021 - nature.com
Lack of dystrophin causes muscle degeneration, which is exacerbated by chronic
inflammation and reduced regenerative capacity of muscle stem cells in Duchenne Muscular …

Immune-mediated pathology in Duchenne muscular dystrophy

AS Rosenberg, M Puig, K Nagaraju… - Science translational …, 2015 - science.org
Immunological and inflammatory processes downstream of dystrophin deficiency as well as
metabolic abnormalities, defective autophagy, and loss of regenerative capacity all …

[HTML][HTML] Current pharmacological strategies for Duchenne muscular dystrophy

S Yao, Z Chen, Y Yu, N Zhang, H Jiang… - Frontiers in Cell and …, 2021 - frontiersin.org
Duchenne muscular dystrophy (DMD) is a lethal, X-linked neuromuscular disorder caused
by the absence of dystrophin protein, which is essential for muscle fiber integrity. Loss of …

[HTML][HTML] Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy

NA Dumont, MA Rudnicki - NPJ Regenerative medicine, 2016 - nature.com
Duchenne muscular dystrophy (DMD) is a genetic disease characterised by skeletal muscle
degeneration and progressive muscle wasting, which is caused by loss-of-function …

[HTML][HTML] Inflammation in duchenne muscular dystrophy–exploring the role of neutrophils in muscle damage and regeneration

A Tulangekar, TE Sztal - Biomedicines, 2021 - mdpi.com
Duchenne muscular dystrophy (DMD) is a severe and progressive, X-linked, neuromuscular
disorder caused by mutations in the dystrophin gene. In DMD, the lack of functional …

Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors

S Miyatake, Y Shimizu-Motohashi… - Drug design …, 2016 - Taylor & Francis
Duchenne muscular dystrophy (DMD), an incurable and a progressive muscle wasting
disease, is caused by the absence of dystrophin protein, leading to recurrent muscle fiber …

Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention

NP Evans, SA Misyak, JL Robertson… - PM&R, 2009 - Elsevier
Duchenne muscular dystrophy is a lethal muscle-wasting disease that affects boys.
Mutations in the dystrophin gene result in the absence of the dystrophin glycoprotein …

[HTML][HTML] Understanding the process of fibrosis in Duchenne muscular dystrophy

Y Kharraz, J Guerra, P Pessina, AL Serrano… - BioMed research …, 2014 - hindawi.com
Fibrosis is the aberrant deposition of extracellular matrix (ECM) components during tissue
healing leading to loss of its architecture and function. Fibrotic diseases are often associated …

VBP15, a novel anti‐inflammatory and membrane‐stabilizer, improves muscular dystrophy without side effects

CR Heier, JM Damsker, Q Yu… - EMBO molecular …, 2013 - embopress.org
Absence of dystrophin makes skeletal muscle more susceptible to injury, resulting in
breaches of the plasma membrane and chronic inflammation in Duchenne muscular …

Duchenne muscular dystrophy: pathogenesis and promising therapies

M Chang, Y Cai, Z Gao, X Chen, B Liu, C Zhang… - Journal of …, 2023 - Springer
Duchenne muscular dystrophy (DMD) is a severe, progressive, muscle-wasting disease,
characterized by progressive deterioration of skeletal muscle that causes rapid loss of …